| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Revenue | $1.79B | +51.9% |
| Cost of Revenue | $1.54B | +56.3% |
| Gross Profit | $245.7M | +29.5% |
| R&D Expense | $173.5M | -11.1% |
| SG&A Expense | $188.9M | -13.3% |
| Operating Income | -$116.7M | +47.7% |
| Pre-tax Income | -$79.7M | +62.5% |
| Income Tax | $4.2M | +191.2% |
| Net Income | -$13.5M |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $727.3M | +181.1% |
| Accounts Receivable | $201.5M | +191.2% |
| Inventory | $106.1M | -22.0% |
| Current Assets | $1.36B | +36.7% |
| Total Assets | $1.58B | +50.2% |
| Current Liabilities | $1.02B | -0.8% |
| Total Liabilities | $1.19B | +12.8% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.1M | -125.2% |
| Capital Expenditures | $42.2M | +169.2% |
| Investing Cash Flow | $156.5M | +152.3% |
| Financing Cash Flow | $371.0M | +1639.5% |
| Free Cash Flow | -$100.3M | -146.6% |
| +43.5% |
| EPS (Basic) | -$0.14 | +62.2% |
| EPS (Diluted) | -$0.14 | +62.2% |
| Stockholders' Equity |
| $197.2M |
| — |